NCT04282057

Brief Summary

The main objective of this study is to compare the effect of 6 sessions of shock wave therapy versus radiofrequency followed by a protocol of moderate aerobic exercise, in the reduction of adiposity and abdominal flaccidity, in females between 18 and 60 years old. As a secondary objective, it is intended to understand the mechanism of fat mobilization by these two therapies.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

February 22, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 19, 2020

Completed
Last Updated

September 30, 2020

Status Verified

September 1, 2020

Enrollment Period

2 months

First QC Date

February 18, 2020

Last Update Submit

September 28, 2020

Conditions

Keywords

shock wave therapyradiofrequencyadipose tissueskin flaccidityaerobic exercise

Outcome Measures

Primary Outcomes (45)

  • Cutaneous abdominal tissue thickness

    Measurement of the cutaneous fold by ultrasonography

    Baseline

  • Cutaneous abdominal tissue thickness

    Measurement of the cutaneous fold by ultrasonography

    3 weeks after

  • Cutaneous abdominal tissue thickness

    Measurement of the cutaneous fold by ultrasonography

    6 weeks after

  • Subcutaneous abdominal tissue thickness

    Measurement of the subcutaneous adipose fold by ultrasonography

    Baseline

  • Subcutaneous abdominal tissue thickness

    Measurement of the subcutaneous adipose fold by ultrasonography

    3 weeks after

  • Subcutaneous abdominal tissue thickness

    Measurement of the subcutaneous adipose fold by ultrasonography

    6 weeks after

  • Glycerol concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    Baseline

  • Glycerol concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    3 weeks after

  • Glycerol concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    6 weeks after

  • Lipid profile (LDL, HDL and triglyceride concentrations)

    Blood analysis collection carried out with help from an clinical analysis technician

    Baseline

  • Lipid profile (LDL, HDL and triglyceride concentrations)

    Blood analysis collection carried out with help from an clinical analysis technician

    3 weeks after

  • Lipid profile (LDL, HDL and triglyceride concentrations)

    Blood analysis collection carried out with help from an clinical analysis technician

    6 weeks after

  • Perimetry

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

    Baseline

  • Perimetry

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

    3 weeks after

  • Perimetry

    Perimetry consists of measuring circumferences. In this case, of the waist at the navel area, 3 cm below it and in the hip area

    6 weeks after

  • Adipometry

    Adipometry consists of measuring skinfold thickness

    Baseline

  • Adipometry

    Adipometry consists of measuring skinfold thickness

    3 weeks after

  • Adipometry

    Adipometry consists of measuring skinfold thickness

    6 weeks after

  • Inflammatory markers concentration (IL6, CRP, TNF)

    Blood analysis collection carried out with help from an clinical analysis technician

    Baseline

  • Inflammatory markers concentration (IL6, CRP, TNF)

    Blood analysis collection carried out with help from an clinical analysis technician

    3 weeks after

  • Inflammatory markers concentration (IL6, CRP, TNF)

    Blood analysis collection carried out with help from an clinical analysis technician

    6 weeks after

  • Nitrous oxide concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    Baseline

  • Nitrous oxide concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    3 weeks after

  • Nitrous oxide concentration

    Blood analysis collection carried out with help from an clinical analysis technician

    6 weeks after

  • Body composition- body mass

    body mass in kilograms

    Baseline

  • Body composition- body mass

    body mass in kilograms

    3 weeks after

  • Body composition- body mass

    body mass in kilograms

    6 weeks after

  • Body composition- muscle mass

    muscle mass in kilograms

    Baseline

  • Body composition- muscle mass

    muscle mass in kilograms

    3 weeks after

  • Body composition- muscle mass

    muscle mass in kilograms

    6 weeks after

  • Body composition- fat mass

    fat mass in kilograms

    Baseline

  • Body composition- fat mass

    fat mass in kilograms

    3 weeks after

  • Body composition- fat mass

    fat mass in kilograms

    6 weeks after

  • Body composition- visceral fat

    visceral fat

    Baseline

  • Body composition- visceral fat

    visceral fat

    3 weeks after

  • Body composition- visceral fat

    visceral fat

    6 weeks after

  • Body composition- fat body areas

    percentage of fat distributed by body areas

    Baseline

  • Body composition- fat body areas

    percentage of fat distributed by body areas

    3 weeks after

  • Body composition- fat body areas

    percentage of fat distributed by body areas

    6 weeks after

  • Thermography

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

    Baseline

  • Thermography

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

    3 weeks after

  • Thermography

    Thermography is used to assess the temperature of the skin surface, and it is also possible to suppose changes in blood flow and vascularization with this outcome

    6 weeks after

  • Photography

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

    Baseline

  • Photography

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

    3 weeks after

  • Photography

    Photography is used to compare the before and after images. With these it is possible to evaluate the skin flaccidity and fat

    6 weeks after

Secondary Outcomes (6)

  • skin flaccidity

    Baseline

  • skin flaccidity

    3 weeks after

  • skin flaccidity

    6 weeks after

  • skin flaccidity and localized fat in the abdomen region

    Baseline

  • skin flaccidity and localized fat in the abdomen region

    3 weeks after

  • +1 more secondary outcomes

Study Arms (3)

shockwave therapy group

EXPERIMENTAL

This group performed aerobic exercise just after shock wave therapy in the abdominal region.

Device: Shock wave therapy

radiofrequency group

EXPERIMENTAL

This group performed aerobic exercise just after radiofrequency in the abdominal region.

Device: Radiofrequency

control group

ACTIVE COMPARATOR

This group only performed aerobic exercise.

Device: Aerobic exercise

Interventions

Radiofrequency protocol - The radiofrequency protocol was performed in dorsal decubitus, with the head elevated at 45 degrees. The application was in capacitive mode, with a 7cm electrode, always in movement. The duration of the application was established in 15 minutes, maintaining the local temperature between 40 to 42 celsius degrees at the epidermis.

radiofrequency group

Aerobic exercise protocol - 40 minutes of aerobic moderate-intensity exercise (45-55% of reserve heart rate) using Karvonen's formula, performed on a cycloergometer. The duration of the exercise was divided into three parts: warm-up (5 minutes); body (30 minutes); and cooling (from 5 to 10 minutes). The entire protocol was monitored through the Polar® brand heart rate monitor and watch.

control group

The shock wave device corresponds to the BTL-6000 X-Wave TM with a 20mm transmitter multifocal. The parameters used correspond to the pressure set between 2.8 and 3.5 bar, frequency 15 hertz and 3000 pulses per 10x15 cm area. It was used as a means contact gel for ultrasound, reference 033-051. In this procedure the participants found themselves in the supine position, with a pillow under the head and with the bending knees.

shockwave therapy group

Eligibility Criteria

Age18 Years - 60 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 18 to 60 years

You may not qualify if:

  • smoking and drinking habits;
  • athletes;
  • people with dietary restrictions;
  • participants who have had diets to lose weight in the last 3 months or who will start during the study;
  • pregnant women;
  • in postpartum less than one year;
  • breastfeeding;
  • intending to become pregnant during the study period;
  • patients with electronic or metallic devices (pacemaker, IUD);
  • individuals with metabolic (including dyslipidemias);
  • hematological and renal disorders;
  • individuals with dermatological changes;
  • cardiovascular, respiratory, digestive, orthopedic, rheumatological and oncological pathologies;
  • changes in the immune system or with acute inflammatory processes;
  • changes in sensitivity or subject to medication (anti-coagulants, corticosteroids up to 6 weeks before, non-steroidal anti-inflammatory drugs, antihistamines, diuretics)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Andreia Noites

Vila Nova de Gaia, Porto District, 4400-330, Portugal

Location

Related Publications (4)

  • Adatto MA, Adatto-Neilson R, Novak P, Krotz A, Haller G. Body shaping with acoustic wave therapy AWT((R))/EPAT((R)): randomized, controlled study on 14 subjects. J Cosmet Laser Ther. 2011 Dec;13(6):291-6. doi: 10.3109/14764172.2011.630089.

    PMID: 21981441BACKGROUND
  • Modena DAO, da Silva CN, Grecco C, Guidi RM, Moreira RG, Coelho AA, Sant'Ana E, de Souza JR. Extracorporeal shockwave: mechanisms of action and physiological aspects for cellulite, body shaping, and localized fat-Systematic review. J Cosmet Laser Ther. 2017 Oct;19(6):314-319. doi: 10.1080/14764172.2017.1334928. Epub 2017 Jun 7.

    PMID: 28590827BACKGROUND
  • Noites A, Vale AL, Pereira AS, Morais A, Vilarinho R, Carvalho P, Amorim M, Moreira T, Mendonca A. Effect of an aerobic exercise session combined with abdominal radiofrequency on lipolytic activity in women: Randomized control trial. J Cosmet Dermatol. 2020 Mar;19(3):638-645. doi: 10.1111/jocd.13056. Epub 2019 Jun 29.

    PMID: 31254455BACKGROUND
  • Vale AL, Pereira AS, Morais A, de Carvalho P, Vilarinho R, Mendonca A, Noites A. Effect of four sessions of aerobic exercise with abdominal radiofrequency in adipose tissue in healthy women: Randomized control trial. J Cosmet Dermatol. 2020 Feb;19(2):359-367. doi: 10.1111/jocd.13036. Epub 2019 Jun 3.

    PMID: 31157522BACKGROUND

MeSH Terms

Conditions

Metabolic Diseases

Interventions

Extracorporeal Shockwave Therapy

Condition Hierarchy (Ancestors)

Nutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Ultrasonic TherapyDiathermyHyperthermia, InducedTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Teacher

Study Record Dates

First Submitted

February 18, 2020

First Posted

February 24, 2020

Study Start

February 22, 2020

Primary Completion

April 25, 2020

Study Completion

June 19, 2020

Last Updated

September 30, 2020

Record last verified: 2020-09

Data Sharing

IPD Sharing
Will not share

Locations